loteprednol
loteprednol (as Loteprednol Etabonate) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use. Loteprednol etabonate is a white to off white powder.chemically it is chloromethyl 17a-[(ethoxycarbonyl)oxy]-11ß-hydroxy-3-oxoandrosta-1,4-diene-17ß-carboxylate. It is used in ophthalmic solution for the treatment of steroid responsive inflammatory conditions of the eye.
Primary Characteristics
It is of Synthetic origin and belongs to Corticosteroids.
Molecular Weight: 394.88 · Non-proprietary name: loteprednol.

Pharmacokinetics
Elimination: it is metabolised via extensive.
Advertisement
Indications
loteprednol is primarily indicated in conditions like Acne rosacea, Conjunctivitis, Herpes zoster, Iritis, Keratitis, Uveitis.
Contraindications
None recorded.
Dosage
loteprednol's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 1.5 % | 1.5 % | Every 6h | opthalmic | Seasonal Allergic Conjunctivitis |
| 1.5 % | 1.5 % | Every 6h | opthalmic | Inflammatory Ocular Disorders |
| 1.5 % | 1.5 % | Every 6h | opthalmic | Post Operative Ocular Inflammation |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
loteprednol is known to cause more or less tolerable side effects which are usually transient. These include anterior chamber inflammation, elevated intraocular presure, Eye Pain , Foreign body sensation, herpes simplex, posterior subcapsular cataract formation.
Warnings / Precautions
Available Brands
Drug Classification
- 1.21.2.1 — Corticosteroids
Manufacturers
Manufacturers of loteprednol in Pakistan: